These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 19795039)

  • 1. Low prevalence and mild course of inflammatory bowel diseases in South Eastern Europe.
    Vadan R; Gheorghe L; Gheorghe C
    J Gastrointestin Liver Dis; 2009 Sep; 18(3):385-6. PubMed ID: 19795039
    [No Abstract]   [Full Text] [Related]  

  • 2. Is the epidemiology of inflammatory bowel disease changing in Eastern Europe?
    Lakatos PL; Fischer S; Lakatos L
    Scand J Gastroenterol; 2006 Jul; 41(7):870-1; author reply 871-2. PubMed ID: 16785204
    [No Abstract]   [Full Text] [Related]  

  • 3. [Epidemiology and risk factors of inflammatory bowel diseases].
    Colombel JF; Vernier-Massouille G; Cortot A; Gower-Rousseau C; Salomez JL
    Bull Acad Natl Med; 2007 Jun; 191(6):1105-18; discussion 1118-23. PubMed ID: 18402167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is the incidence and prevalence of inflammatory bowel diseases increasing in Eastern Europe?
    Lakatos L; Lakatos PL
    Postgrad Med J; 2006 May; 82(967):332-7. PubMed ID: 16679472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory bowel disease treatment in Eastern Europe: current status, challenges and needs.
    Khalif IL; Shapina MV
    Curr Opin Gastroenterol; 2017 Jul; 33(4):230-233. PubMed ID: 28509785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lower prevalence of Helicobacter pylori infection in patients with inflammatory bowel disease but not with chronic obstructive pulmonary disease - antibiotic use in the history does not play a significant role.
    Prónai L; Schandl L; Orosz Z; Magyar P; Tulassay Z
    Helicobacter; 2004 Jun; 9(3):278-83. PubMed ID: 15165265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory bowel disease in the elderly.
    Grimm IS; Friedman LS
    Gastroenterol Clin North Am; 1990 Jun; 19(2):361-89. PubMed ID: 2194950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Descriptive epidemiology of inflammatory bowel disease in Spain].
    García-Paredes J; Mendoza JL
    An Med Interna; 2003 Jan; 20(1):1-2. PubMed ID: 12666300
    [No Abstract]   [Full Text] [Related]  

  • 9. [Incidence of inflammatory bowel disease in Sagunto].
    Hinojosa J; Primo J; Lledó S; López A; Roig JV; Fernández J
    Rev Esp Enferm Dig; 1990 Nov; 78(5):283-7. PubMed ID: 2090171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Epidemiology and risk factors of inflammatory bowel diseases].
    Vernier G; Cortot A; Gower-Rousseau C; Salomez JL; Colombel JF
    Rev Prat; 2005 May; 55(9):949-61. PubMed ID: 16052966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The low prevalence of helicobacter infection in patients with inflammatory bowel disease could be attributed to previous antibiotic treatment.
    Triantafillidis JK; Gikas A; Apostolidiss N; Merikas E; Mallass E; Peros G
    Am J Gastroenterol; 2003 May; 98(5):1213-4. PubMed ID: 12809861
    [No Abstract]   [Full Text] [Related]  

  • 12. The prevalence of inflammatory bowel disease in patients with primary sclerosing cholangitis.
    Osmanoğlu N; Tekin F; Ozütemiz O; Ersöz G; Tekeşin O
    Turk J Gastroenterol; 2005 Dec; 16(4):240-1. PubMed ID: 16547857
    [No Abstract]   [Full Text] [Related]  

  • 13. How much inflammatory bowel disease is there?
    Langman M
    Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):54-5. PubMed ID: 9615267
    [No Abstract]   [Full Text] [Related]  

  • 14. Periodontal treatment needs in Central and Eastern Europe.
    Gera I
    J Int Acad Periodontol; 2000 Oct; 2(4):120-8. PubMed ID: 12666970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validity and completeness of the General Practice Research Database for studies of inflammatory bowel disease.
    Lewis JD; Brensinger C; Bilker WB; Strom BL
    Pharmacoepidemiol Drug Saf; 2002; 11(3):211-8. PubMed ID: 12051120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysplasia and cancer in inflammatory bowel disease 10 years after diagnosis: results of a population-based European collaborative follow-up study.
    Katsanos KH; Vermeire S; Christodoulou DK; Riis L; Wolters F; Odes S; Freitas J; Hoie O; Beltrami M; Fornaciari G; Clofent J; Bodini P; Vatn M; Nunes PB; Moum B; Munkholm P; Limonard C; Stockbrugger R; Rutgeerts P; Tsianos EV;
    Digestion; 2007; 75(2-3):113-21. PubMed ID: 17598963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Incidence and prevalence of inflammatory bowel disease in Gijon, Asturias, Spain].
    Saro Gismera C; Lacort Fernández M; Argüelles Fernández G; Antón Magarzo J; García López R; Navascues CA; Suárez González A; Díaz Alvarez G; González Bernal A; Palacios Galán A; Altadill Arregui A; Vizoso F
    Gastroenterol Hepatol; 2000; 23(7):322-7. PubMed ID: 11002532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Genetics of inflammatory bowel diseases].
    Hugot JP; Laurent-Puig P; Thomas G
    Gastroenterol Clin Biol; 1995 Nov; 19(11):890-8. PubMed ID: 8746047
    [No Abstract]   [Full Text] [Related]  

  • 19. Autoimmune disorders in patients affected by celiac sprue and inflammatory bowel disease.
    Bardella MT; Elli L; De Matteis S; Floriani I; Torri V; Piodi L
    Ann Med; 2009; 41(2):139-43. PubMed ID: 18777226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of inflammatory bowel disease in Italy.
    Cottone M; Martorana G; Di Mitri R; Cammà C; Caprilli R
    Ital J Gastroenterol Hepatol; 1999; 31(6):503-7. PubMed ID: 10575570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.